Skip to content

Comparing the effect of supplementary injection on inferior alveolar nerve block success rate

Comparing the effect of supplementary buccal and/or lingual articaine infiltration on inferior alveolar nerve block success rate in symptomatic irreversible pulpitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015112715782N3
Enrollment
160
Registered
2016-04-26
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irriversible pulpitis.

Interventions

Intervention 1: intervention group 1: block injection with articaine buccal infiltration. Intervention 2: intervention group 2: block injection with articaine lingual infiltration. Intervention 3: int
Treatment - Other
intervention group 1: block injection with articaine buccal infiltration
intervention group 2: block injection with articaine lingual infiltration
intervention group 3: block injection with articaine buccal and lingual infiltration
control group: block injectin without any supplementary injectoin

Sponsors

investigator
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:patients between 18 to 65 years old; without any systematic disease or drug using; no allergic reaction to the anesthetic; no smoking; not using analgesic 24 hours ago; no pregnant or breastfeeding and they must have one molar with irreversible pulpitis. Exclusion criteria: pulp necrosis; periapical radioluscency.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 15 minute after injection. Method of measurement: Heft Parker visual analog scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSetareh Ghannad

Tehran Medical Science Branch,Islamic Azad University

Ghannad.setareh@yahoo.com+98 21 8868 1285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026